Discover

'''Candida albicans''' is a diploid fungus (a form of yeast), which is capable of mating but not of meiosis, and a causal agent of opportunistic and genital infections in humans. Sherris Medical Microbiology, Ryan KJ; Ray CG (editors), , , McGraw Hill, 2004, ISBN 0838585299 Candida: Comparative and Functional Genomics, dEnfert C; Hube B (editors), , , Caister Academic Press, 2007, ISBN 9781904455134 Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in immunocompromised patients (''e.g.'', AIDS, cancer chemotherapy, organ or bone marrow transplantation). In addition, hospital-related infections in patients not previously considered at risk (''e.g.'' patients on an intensive care unit) have become a cause of major health concern.
''C. albicans'' is among the gut flora, the many organisms that live in the human mouth and gastrointestinal tract. Under normal circumstances, ''C. albicans'' lives in 80% of the human population with no harmful effects, although overgrowth results in candidiasis. Candidiasis is often observed in immunocompromised individuals such as HIV-positive patients. Candidiasis also may occur in the blood and in the genital tract. Candidiasis, also known as "thrush", is a common condition that is usually easily cured in people who are not immunocompromised. To infect host tissue, the usual unicellular yeast-like form of ''Candida albicans'' reacts to environmental cues and switches into an invasive, multicellular filamentous form.

Contents

Genome

Dimorphism

See also

References

External links

Genome

One of the most interesting features of the ''C. albicans'' genome is the occurrence of numeric and structural chromosomal rearrangements as means of generating genetic diversity, named chromosome length polymorphisms (contraction/expansion of repeats), reciprocal translocations, chromosome deletions and trisomy of individual chromosomes. These karyotypic alterations lead to changes in the phenotype, which is an adaptation strategy of this fungus. These mechanisms will be better understood with the complete analysis of the ''C. albicans'' genome.
The ''Candida albicans'' genome for strain SC5314 was sequenced at the Stanford DNA Sequencing and Technology Center^[1][2]. The genome of the WO1 strain was sequenced by the Broad Institute of MIT and Harvard [1].
The sequencing of the ''C. albicans'' genome and subsequently of the genomes of several other medically relevant ''Candida'' species has profoundly and irreversibly changed the way ''Candida'' species are now investigated and understood Candida: Comparative and Functional Genomics, dEnfert C; Hube B (editors), , , Caister Academic Press, 2007, ISBN 9781904455134 . The ''C. albicans'' genome sequencing effort was launched in October 1996. Successive releases of the sequencing data and genome assemblies have marked the last 10 years, culminating with the release of the diploid assembly 19 that provided a haploid version of the genome along with data on allelic regions in the genome Candida: Comparative and Functional Genomics, dEnfert C; Hube B (editors), , , Caister Academic Press, 2007, ISBN 9781904455134 . A refined assembly 20 with the eight assembled ''C. albicans'' chromosomes has been released in the summer of 2006. Importantly, the availability of sequencing data prior to the completion of the genome sequence has made it possible to start ''C. albicans'' post-genomics early on. In this regard, genome databases have been made available to the research community providing different forms of genome annotation. These have been merged in a community-based annotation hosted by the ''Candida'' Genome Database. The availability of the genome sequence has paved the way for the implementation of post-genomic approaches to the study of ''C. albicans'': macroarrays and then microarrays have been developed and used to study the ''C. albicans'' transcriptome; proteomics has also been developed and complements transcriptional analyses; furthermore, systematic approaches are becoming available to study the contribution of each ''C. albicans'' gene in different contexts. Other ''Candida'' genome sequences have been, or are being, determined: ''C. glabrata'', ''C. dubliniensis'', ''C. parapsilosis'', ''C. guilliermondii'', ''C. lusitaniae'', and ''C. tropicalis''. These species will soon enter the post-genomic era as well and provide interesting comparative data. The genome sequences obtained for the different ''Candida'' species along with those of non-pathogenic hemiascomycetes provide a wealth of knowledge on the evolutionary processes that have shaped the hemiascomycete group as well as those that may have contributed to the success of different ''Candida'' species as pathogens Candida: Comparative and Functional Genomics, dEnfert C; Hube B (editors), , , Caister Academic Press, 2007, ISBN 9781904455134 .
The genome of ''C. albicans'' is highly dynamic and this variability has been used advantageously for molecular epidemiological studies of ''C. albicans'' and population studies in this species. A remarkable discovery that has arisen from the genome sequence is the presence of a parasexual cycle in ''C. albicans''. This parasexual cycle is under the control of mating-type loci and switching between white and opaque phenotypes. Investigating the role that the mating process plays in the dynamics of the ''C. albicans'' population or in other aspects of ''C. albicans'' biology and pathogenicity will undoubtedly represent an important focus for future research Candida: Comparative and Functional Genomics, dEnfert C; Hube B (editors), , , Caister Academic Press, 2007, ISBN 9781904455134 .

Dimorphism

In a process that superficially resembles dimorphism, ''C. albicans'' undergoes a process called phenotypic switching, in which different cellular morphologies are generated spontaneously. One of the classically studied strains that undergoes phenotypic switching is WO-1, which consists of two phases - one that grows as smooth white colonies and one that is rod-like and grows as flat gray colonies. The other strain known to undergo switching is 3153A; this strain produces at least seven different colony morphologies. In both the WO-1 and 3153A strains, the different phases convert spontaneously to the other(s) at a low frequency. The switching is reversible, and colony type can be inherited from one generation to another. While several genes that are expressed differently in different colony morphologies have been identified, some recent efforts have focused on what might be controlling these changes. Further, whether there is a potential molecular link between dimorphism and phenotypic switching is a tantalizing question.
In the 3153A strain, a gene called SIR2 (for silent information regulator) has been found that seems to be important for phenotypic switching. SIR2 was originally found in ''Saccharomyces cerevisiae'' (brewer's yeast), where it is involved in chromosomal silencing — a form of transcriptional regulation in which regions of the genome are reversibly inactivated by changes in chromatin structure (chromatin is the complex of DNA and proteins that make chromosomes). In yeast, genes involved in the control of mating type are found in these silent regions, and SIR2 represses their expression by maintaining a silent-competent chromatin structure in this region. The discovery of a ''C. albicans'' SIR2 that is implicated in phenotypic switching suggests that it too has silent regions controlled by SIR2, in which the phenotype-specific genes may perhaps reside.
Another potential regulatory molecule is Efg1p, a transcription factor found in the WO-1 strain that regulates dimorphism, and more recently has been suggested to help regulate phenotypic switching. Efg1p is expressed only in the white and not in the gray cell-type, and overexpression of Efg1p in the gray form causes a rapid conversion to the white form.
So far there are few data that says that dimorphism and phenotypic switching use common molecular components. However, it is not inconceivable that phenotypic switching may occur in response to some change in the environment as well as being a spontaneous event. How SIR2 itself is regulated in ''Saccharomyces cerevisiae'' may yet provide clues as to the switching mechanisms of ''C. albicans''.

See also

★ Torula yeast (''Candida utilis'')

★ Psoriasis

★ Undecylenic acid (Castor oil derivative) for candida fungus infections.

References

1. The diploid genome sequence of Candida albicans, Jones T, Federspiel N, Chibana H, Dungan J, Kalman S, Magee B, Newport G, Thorstenson Y, Agabian N, Magee P, Davis R, Scherer S, , , Proc Natl Acad Sci U S A, 2004
2. A human-curated annotation of the Candida albicans genome, Braun B, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis D, Uhl M, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro C, Bates S, Gow N, Hoyer L, K�hler G, Morschh�user J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell A, Johnson A, Whiteway M, Nantel A, , , PLoS Genet, 2005

External links

★ U.S. National Institutes of Health on the ''Candida albicans'' genome

★ Causes for candida albicans & Natural Herbal Treatment, FAQ

★ NIH - How ''Candida albicans'' switches phenotype

★ ''Candida albicans'' genome

★ ''Candida'' genomics

★ Eczema, psoriasis, Chronic Rashes, and their relationship to Candida albicans

★ Incidence of Candida in psoriasis--a study on the fungal flora of psoriatic patients